Polar Capital Holdings Plc boosted its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 33.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 874,813 shares of the company’s stock after buying an additional 217,623 shares during the period. Polar Capital Holdings Plc owned about 0.29% of Stevanato Group worth $19,062,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the business. First Bank & Trust boosted its stake in Stevanato Group by 7.3% during the fourth quarter. First Bank & Trust now owns 15,145 shares of the company’s stock worth $330,000 after buying an additional 1,036 shares in the last quarter. Truist Financial Corp boosted its stake in shares of Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock valued at $586,000 after purchasing an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Stevanato Group by 9.7% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company’s stock valued at $281,000 after purchasing an additional 1,141 shares in the last quarter. US Bancorp DE boosted its stake in shares of Stevanato Group by 17.9% in the 4th quarter. US Bancorp DE now owns 8,527 shares of the company’s stock valued at $186,000 after purchasing an additional 1,295 shares in the last quarter. Finally, Advisors Capital Management LLC boosted its stake in shares of Stevanato Group by 1.0% in the 4th quarter. Advisors Capital Management LLC now owns 170,776 shares of the company’s stock valued at $3,721,000 after purchasing an additional 1,735 shares in the last quarter.
Stevanato Group Stock Down 2.3%
Shares of NYSE STVN opened at €23.17 ($26.03) on Friday. The firm’s 50-day simple moving average is €21.35 and its 200 day simple moving average is €21.14. The company has a market cap of $7.02 billion, a price-to-earnings ratio of 49.30, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.61) and a 12-month high of €24.96 ($28.04).
Stevanato Group Increases Dividend
The firm also recently announced an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be given a dividend of $0.0613 per share. The ex-dividend date is Thursday, June 5th. This is an increase from Stevanato Group’s previous annual dividend of $0.05. This represents a yield of 0.3%. Stevanato Group’s dividend payout ratio is presently 11.76%.
Analyst Ratings Changes
Several equities research analysts have recently commented on the stock. William Blair restated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Stephens upgraded shares of Stevanato Group to a “strong-buy” rating in a research note on Monday, April 21st. Finally, UBS Group reduced their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of €25.70 ($28.88).
Get Our Latest Report on Stevanato Group
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
- Five stocks we like better than Stevanato Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Walmart Stock Alert: Big Price Move Expected Soon
- Best Aerospace Stocks Investing
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Why Invest in 5G? How to Invest in 5G Stocks
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.